Intelligent Bio Solutions Inc.
INBS
$1.70
-$0.06-3.41%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.06% | -2.31% | 20.16% | 12.08% | 4.47% |
| Total Depreciation and Amortization | 0.05% | 9.10% | 5.09% | -5.16% | 25.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 438.65% | 246.98% | -88.82% | -93.44% | -96.65% |
| Change in Net Operating Assets | -2.71% | -183.26% | -168.42% | -203.59% | -989.61% |
| Cash from Operations | -1.11% | -44.36% | -38.70% | -56.68% | -29.74% |
| Capital Expenditure | -4.70% | -252.31% | -202.44% | -630.69% | 56.18% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -4.70% | 19.20% | -168.32% | -0.96% | 68.11% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -68.42% | -72.51% | 257.04% | 471.66% | 469.99% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | 1,276.34% | 1,276.34% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | 140.33% | 100.00% | 100.00% |
| Cash from Financing | -68.42% | -72.60% | 106.28% | 917.42% | 914.46% |
| Foreign Exchange rate Adjustments | 4,633.33% | 128.77% | -932.20% | 195.26% | 99.07% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -210.85% | -192.60% | 162.66% | 168.45% | 171.14% |